Company Active Biotech AB Xetra
Equities
BTPC
SE0001137985
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
05-22 | Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug | MT |
05-22 | Active Biotech Enters into an Exclusive License Agreement with the Wistar Institute of Anatomy and Biology | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Helén Tuvesson
CEO | Chief Executive Officer | 62 | 97-12-31 |
Hans Kolam
DFI | Director of Finance/CFO | 73 | 99-12-31 |
Erik Vahtola
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 19-05-22 |
Director/Board Member | 50 | 19-12-31 | |
Michael Shalmi
CHM | Chairman | 59 | 19-05-22 |
Director/Board Member | 68 | 11-04-04 | |
Director/Board Member | 64 | 19-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 361,739,000 | 254,636,402 ( 70.39 %) | 0 | 70.39 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- ACTI Stock
- BTPC Stock
- Company Active Biotech AB